Outcomes of a multidisciplinary approach to management of mavacamten in obstructive hypertrophic cardiomyopathy
The described workflow effectively addressed challenges associated with mavacamten management, emphasizing roles for clinic personnel, cost reduction strategies, and structured patient monitoring. While the workflow's specifics may need adaptation in different settings, this report provides valuable insights for clinics implementing structured mavacamten management approaches.
Authors
- Trista Boarman
- Megan Kraushaar
- Zaid Yousif
- Jorge Silva Enciso (ORCID: https://orcid.org/0000-0002-9493-0932)
- Andrew Willeford (ORCID: https://orcid.org/0000-0002-2146-3624)
- Trina Huynh
- Hanna Jensen (ORCID: https://orcid.org/0000-0001-8487-7982)
- Marcy Reed
Institutions
- UC San Diego Health System (US)
- University of California San Diego (US)
- University of Montana (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1093/ajhp/zxae372
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00